Cautiously Optimistic Analyst Sentiment on Mereo BioPharma Group (MREO) Following Disappointing Phase 4 Data for Setrusumab
Mereo BioPharma Group plc (NASDAQ:MREO) is included in our list of the stocks under $1 that will explode.
Mereo Biopharma Group Plc (MREO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 15,307,347 | $4,863,144 | 0.04% | |
| 2. | 683 Capital Partners Ari Zweiman | 11,777,856 | $3,741,825 | -2% | 0.18% |
| 3. | Defilade Capital Jonathan Forman | 7,558,756 | $2,401,417 | 0.32% | |
| 4. | Newtyn Management Noah Levy And Eugene Dozortsev | 3,000,000 | $953,100 | -58% | 0.12% |
| 5. | EcoR1 Capital Oleg Nodelman | 1,000,000 | $317,700 | -93% | 0.02% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.22 | 60,046 | $253,454.17 | 808,921 | 2024-09-13 | Filing | |
| $4.47 | 28,611 | $127,968.42 | 868,967 | 2024-09-12 | Filing | |
| $4.22 | 10,937 | $46,165.08 | 78,630 | 2024-09-13 | Filing | |
| $4.47 | 5,212 | $23,311.71 | 89,567 | 2024-09-12 | Filing | |
| $4.22 | 20,946 | $88,413.07 | 219,061 | 2024-09-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,195,281 | $2,597,904 | 0% | |
| 2. | 2,037,520 | $647,320 | 0.27% | |
| 3. | 1,447,627 | $460,346 | 0% | |
| 4. | 774,944 | $246,200 | 0% | |
| 5. | 768,750 | $244,232 | 0.18% |
News See All
10 Stocks Under $1 That Will Explode
In this piece, we discuss the 10 Stocks Under $1 That Will Explode. U.S.
Mereo BioPharma Group (MREO) Announced Progress in the Phase 3 Orbit Study Testing UX143
Mereo BioPharma Group plc (NASDAQ:MREO) is one of the Best 52-Week Low Penny Stocks to Buy Now.
10 Best 52-Week Low Penny Stocks to Buy Now
In this article, we will look at the 10 Best 52-Week Low Penny Stocks to Buy Now. On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond.
Mereo BioPharma Group plc (MREO): A Bull Case Theory
We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on MREO.
13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
12 Best Biotech Penny Stocks To Invest In Now
Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.
8 Hot Penny Stocks To Invest In According to Hedge Funds
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds.
Mereo BioPharma Group plc (MREO): A Bull Case Theory
We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Raging Bull Investments’ Substack by Jake LaMotta. In this article we will summarize the bulls’ thesis on MREO.
15 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the 15 top performing European stocks so far in 2024.
Hedge Fund Resource Center